Skip to main content

Table 1 Baseline characteristics

From: The performance of different classification criteria sets for spondyloarthritis in the worldwide ASAS-COMOSPA study

 

Total patients (n = 3942)

Based on available data

Number of patients with missing items

Age at inclusion, years, mean ± SD

43.6 (13.9)

 

0

Male sex, n (%)

2563 (65.0%)

 

0

HLA-B27-positive, n (%)

2217 (56.2%)

72.0%

882

IBP, n (%)

3219 (81.7%)

 

52

Morning stiffness, n (%)

2497 (63.3%)

 

22

Enthesitis, n (%)

1354 (34.3%)

 

0

Dactylitis, n (%)

610 (15.5%)

 

3

Psoriasis, n (%)

843 (21.4%)

 

0

Uveitis, n (%)

771 (19.6%)

 

0

Peripheral arthritis, n (%)

2424 (61.5%)

 

0

IBD, n (%)

209 (5.3%)

 

0

Positive family history, n (%)

1475 (37.4%)

 

117

Good response to NSAIDs, n (%)

2433 (61.7%)

77.5%

803

Elevated CRP, n (%)

2109 (53.5%)

57.7%

287

Preceding infection, n (%)

271 (6.9%)

 

74

Sacroiliitis based on radiograph (mNY), n (%)

2539 (64.4%)

70.0%

341

Sacroiliitis based on MRI, n (%)

1326 (33.6%)

65.7%

1951

Rheumatoid factor-negative, n (%)

3177 (80.6%)

94.8%

613

Psoriatic nail dystrophy, n (%)

460 (11.7%)

 

28

Juxta-articular bone formation, n (%)

526 (13.3%)

17.7%

999

  1. Abbreviations: IBP Inflammatory back pain according to Assessment of SpondyloArthritis international Society definition (reference), IBD Inflammatory bowel disease, CRP C-reactive protein, ESR Erythrocyte sedimentation rate, HLA-B27 Human leucocyte antigen, mNY Modified New York criteria, NSAID Non-steroidal anti-inflammatory drug, MRI Magnetic resonance imaging